Farmaregistro S.A. de C.V. owns the domain that is the query: registrosanitarioelsalvador.com (retrieved 23 August 2026). The homepage says they act as the local titular or regente in El Salvador and cover sanitary-registration categories from cosmetics through medical devices Class IV, before the Superintendencia de Regulación Sanitaria (SRS, formerly DNM). That is a one-country titular / regente. This article names that offer, then explains when bioaccess® is the multi-country holder instead.
What Farmaregistro publishes
Public claims on the homepage:
- 30+ years of experience (their figure).
- Agile SRS management and dossier preparation to reduce preventions.
- “Actuamos como tu titular o regente local en El Salvador.”
- 360° regulatory support from cosmetics through device Class IV; also pharmaceutical, food/beverage, and veterinary product tiles.
- Certification and liaison before SRS (ex-DNM).
- Direct contact with the responsible professional, without intermediaries (their wording).
- Clients in Central America, Mexico, the United States, France, India, Germany, Switzerland, Peru, “among others” — countries only; this page does not invent or copy named manufacturers.
- San Salvador address published: Residencial Cima 1 #12-S, Calle 1.
Since 7 August 2024 the Superintendencia de Regulación Sanitaria regulates medical devices as successor to DNM. El Salvador is a single local legal representative per registration. That is why “we will be your titular or regente” is the product that matches the statute — and why giving that role to an exclusive distributor is hard to unwind. Experience-based clocks on the bioaccess® market-access page put DNM/SRS device approvals on the order of ~30–60 days. There is no separate bioaccess® /market-access/el-salvador country page as of this writing; El Salvador is named on the hub and the IOR guide.
Farmaregistro vs bioaccess®
| Dimension | Farmaregistro S.A. de C.V. | bioaccess® |
|---|---|---|
| Public product | Titular / regente local + SRS dossiers, many product classes | LATAM Launch Subscription for already-cleared devices |
| Device reach they publish | Through Class IV | Device registration as part of 19-market coverage; DNM/SRS named on the hub |
| Geography | El Salvador (domain owns the country query) | 19 markets; own entities; holder not leverage |
| Bundle | Country RA / titular | Gov fees + certified translations in one annual fee; Trial-to-Market Bridge 20% |
The LATAM Launch Subscription from bioaccess® is a different product. bioaccess® registers already FDA-cleared (510(k)/PMA) or CE-marked devices and holds them through its own in-country entities — sanitary registration, registration holder / importer of record, certified Spanish or Portuguese translations (sworn where Brazil and Argentina require it), and government submission fees, inside one annual subscription per country and device family. Public coverage is described as 19 LATAM markets. The registration is held for the manufacturer’s benefit, with defined transfer provisions; it is not leverage. Clinical-trial clients of bioaccess® receive the published Trial-to-Market Bridge (20% off). Specific rates are under review; contact bioaccess® for a quote.
Farmaregistro is a fair SRS titular when El Salvador is the only label. bioaccess® is the operator when the same family must also be held in Mexico, Colombia, Brazil, or Argentina under one subscription, with the local face never becoming the commercial channel.
If the plan is one country and a homegrown titular is enough, hire the shop that actually publishes that job. If the plan is several LATAM labels under one holder who is not the distributor, start at bioaccess® market access or request a registration quote.
Leave a Reply